Buy MDMB-4en-PINACA Online for Sale – Comprehensive Guide

Where to Buy MDMB-4en-PINACA Online – Trusted Vendors and Sources

When it comes to buying MDMB-4en-PINACA online, finding a reliable vendor is crucial. There are many sources that offer MDMB-4en-PINACA for sale, but selecting a trusted vendor ensures that you receive a high-quality product. Make sure the vendor offers secure payment options, reliable shipping, and positive customer reviews. Whether you’re in the USA, Canada, or other parts of the world, choose a vendor who ships discreetly and guarantees the authenticity of the chemical.

How to Order MDMB-4en-PINACA – A Step-by-Step Guide for Safe Purchases

Ordering MDMB-4en-PINACA online is simple, but it’s important to follow the correct process for a safe transaction. First, select a reputable MDMB-4en-PINACA shop that offers secure payment methods and discreet shipping. Be sure to check whether the vendor ships to your location, whether you’re in the USA, Canada, or internationally. Once you’ve placed your order, track the shipping progress to ensure safe and timely delivery.

MDMB-4en-PINACA for Sale – Best Deals and Discounts

If you’re interested in purchasing MDMB-4en-PINACA for sale, you can often find deals and discounts available from different vendors. Many shops offer competitive pricing, especially for bulk orders. Be sure to compare offers to find the best deal on MDMB-4en-PINACA while ensuring the vendor’s reliability. Some vendors may also offer special promotions like free shipping or first-time buyer discounts, making it easier to secure this research chemical at a lower cost.

Summary

MDMB-4en-PINACA, often erroneously referred to as 5-CL-ADB-A, is an indazole-based synthetic cannabinoid that has gained popularity as an online designer drug. In 2021, the Drug Enforcement Administration (DEA) in the United States reported MDMB-4en-PINACA as the most prevalent synthetic cannabinoid in circulation.[8] Notably, MDMB-4en-PINACA distinguishes itself from 5F-MDMB-PINACA by substituting the 5-fluorophenyl group with a pent-4-ene moiety (4-en).

Identifiers
IUPAC name
CAS Number2504100-70-1 
PubChem CID155804661
ChemSpider71117180
UNIIK2DZN2TDD6
Chemical and physical data
FormulaC20H27N3O3
Molar mass357.454 g·mol−1

Legal status

On December 18, 2019, Sweden’s public health agency recommended the classification of MDMB-4en-PINACA as a hazardous substance.
In the United States, the DEA has issued a notice of its intent to provisionally categorize MDMB-4en-PINACA as a Schedule I controlled substance, with an effective date on or after May 4, 2023, lasting for up to 2 years. During this period, the DEA may pursue permanent scheduling. If filed on May 4, 2023, and endless scheduling is not followed, the temporary Schedule I designation will expire on May 4, 2025.
As of April 27, 2023, North Dakota has already designated MDMB-4en-PINACA as a Schedule I controlled substance.

FAQ

  • What is MDMB-4en-PINACA?
  • MDMB-4en-PINACA is a synthetic cannabinoid that has gained attention as a designer drug. It belongs to a class of chemicals designed to mimic the effects of cannabinoids found in the cannabis plant.
  • Is MDMB-4en-PINACA Legal?
  • The legal status of MDMB-4en-PINACA varies by jurisdiction. In some places, it may be classified as a controlled substance, while in others, it may not have a specific legal status.
  • What Are the Effects of MDMB-4en-PINACA?
  • The effects of MDMB-4en-PINACA can include relaxation, altered perception, and increased heart rate. However, it can also lead to anxiety, paranoia, and other adverse effects.
  • Is MDMB-4en-PINACA Safe to Use?
  • The safety of using MDMB-4en-PINACA needs to be well-documented, and it may pose health risks. The lack of research and regulation means the purity and safety of products containing this substance can vary.
  • How is MDMB-4en-PINACA Consumed?
  • MDMB-4en-PINACA is typically inhaled as a vapour, but it can also be ingested or used in other ways. The method of use and dosage can significantly impact the potential risks and effects.
  • Is MDMB-4en-PINACA Addictive?
  • Synthetic cannabinoids like MDMB-4en-PINACA can be habit-forming, and some individuals have reported withdrawal symptoms when discontinuing use. The potential for addiction varies from person to person.
  • Can MDMB-4en-PINACA Be Detected in Drug Tests?
  • MDMB-4en-PINACA and similar synthetic cannabinoids might not be detected in standard drug tests. However, some specialized tests can identify their presence.
  • Are There Health Risks Associated with MDMB-4en-PINACA?
  • Yes, there are health risks associated with MDMB-4en-PINACA use. These risks may include cardiovascular problems, anxiety, paranoia, and adverse psychological effects. The lack of quality control in illicit products makes it difficult to predict the exact risks.
  • Can MDMB-4en-PINACA be used for Medical Purposes?
  • MDMB-4en-PINACA is not approved for medical use nor considered a safe or effective treatment for any medical condition. It is strictly intended for research purposes.
  • Where Can I Get Help or More Information About MDMB-4en-PINACA?
  • If you have concerns about MDMB-4en-PINACA or need assistance with substance abuse, seek help from a medical professional, addiction specialist, or helpline. Additionally, reliable sources like government health agencies can provide information on the potential risks associated with this substance.

References

  1. Anvisa (2023-07-24) – “RDC Nº 804 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial” [Collegiate Board Resolution No. 804 – Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Published in Diário Oficial da União on 2023-07-25. Archived from the original on 2023-08-27. Retrieved on 2023-08-27.
  2. Watanabe S, Vikingsson S, Åstrand A, Gréen H, Kronstrand R (December 2019) – “Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.” Published in The AAPS Journal, Volume 22, Issue 1, Page 13. DOI: 10.1208/s12248-019-0381-3. PMID: 31848852. S2CID: 209393242.
  3. “MDMB-4en-PINACA” – Available at www.caymanchem.com.
  4. Erol Ozturk Y, Yeter O (January 2021) – “In Vitro Phase I Metabolism of the Recently Emerged Synthetic MDMB-4en-PINACA and Its Detection in Human Urine Samples.” Published in the Journal of Analytical Toxicology, Volume 44, Issue 9, Pages 976–984. DOI: 10.1093/jat/bkaa017. PMID: 32091101.
  5. Wang Y, Pan Y, Yang H, Liu J, Wurita A, Hasegawa K (July 2022) – “Quantification of MDMB-4en-PINACA and ADB-BUTINACA in human hair by gas chromatography-tandem mass spectrometry.” Published in Forensic Toxicology, Volume 40, Issue 2, Pages 340–348. DOI: 10.1007/s11419-022-00615-z. PMID: 36454410. S2CID: 247501663.
  6. Wagmann L, Stiller RG, Fischmann S, Westphal F, Meyer MR (October 2022) – “Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterases.” Published in Archives of Toxicology, Volume 96, Issue 10, Pages 2755–2766. DOI: 10.1007/s00204-022-03332-z. PMC: 9352624. PMID: 35788413. S2CID: 250281976.
  7. Giorgetti A, Brunetti P, Pelotti S, Auwärter V (October 2022) – “Detection of AP-237 and synthetic cannabinoids on an infused letter sent to a German prisoner.” Published in Drug Testing and Analysis, Volume 14, Issue 10, Pages 1779–1784. DOI: 10.1002/dta.3351. PMC: 9804899. PMID: 35918775. S2CID: 251281159.
  8. “Emerging Threat Report” (PDF) – Published by the Drug Enforcement Administration in 2021.
  9. “ANALYTICAL REPORT MDMB-PINACA N1-pentyl-4-en isomer” (PDF) – Available at www.policija.si.
  10. Krotulski AJ, Cannaert A, Stove C, Logan BK (February 2021) – “The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.” Published in Drug Testing and Analysis, Volume 13, Issue 2, Pages 427–438. DOI: 10.1002/dta.2935. PMID: 32997377. S2CID: 222148050.
  11. Cannaert A, Sparkes E, Pike E, Luo JL, Fang A, Kevin RC, et al. (December 2020) – “Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids.” Published in ACS Chemical Neuroscience, Volume 11, Issue 24, Pages 4434–4446. DOI: 10.1021/acschemneuro.0c00644. PMID: 33253529. S2CID: 227246346.
  12. Pike E, Grafinger KE, Cannaert A, Ametovski A, Luo JL, Sparkes E, et al. (July 2021) – “Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays: Part I.” Published in Drug Testing and Analysis, Volume 13, Issue 7, Pages 1383–1401. DOI: 10.1002/dta.3037. PMID: 33787091.
  13. Grafinger KE, Cannaert A, Ametovski A, Sparkes E, Cairns E, Banister SD, et al. (July 2021) – “Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays-Part II.” Published in Drug Testing and Analysis, Volume 13, Issue 7, Pages 1402–1411. DOI: 10.1002/dta.3035. PMID: 33769699.
  14. “Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara” [Twenty-three substances are proposed to be classified as narcotics or health hazards]. Published by Folkhälsomyndigheten [The Public Health Authority] (in Swedish) on 18 December 2019. Archived from the original on 19 December 2019.
  15. “Federal Register :: Request Access.”
  16. “AN ACT to amend and reenact sections 19-03.1-05, 19-03.1-11, and 19-03.1-13 of the North Dakota Century Code, relating to the scheduling of controlled substances; and to declare an emergency” (PDF). Published by the Sixty-eighth Legislative Assembly of North Dakota in Regular Session on 3 January 2023.

Leave a Reply

Your email address will not be published. Required fields are marked *